SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001102624-15-000981
Filing Date
2015-06-22
Accepted
2015-06-22 08:40:45
Documents
2
Period of Report
2015-06-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CORCEPT THERAPEUTICS 8-K corcept8k.htm 8-K 6350
2 PRESS RELEASE corcepttherapeutics.htm EX-99 5794
  Complete submission text file 0001102624-15-000981.txt   13343
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 15943761
SIC: 2834 Pharmaceutical Preparations